If you or a loved one were treated with Topamax® or Topiramate during pregnancy and had a child born with cleft lip or cleft palate, you may be entitled to recover money in a lawsuit. Contact a lawyer for a free review.
A team of class action attorneys and personal injury lawyers has launched an investigation into Topamax®, a seizure, epilepsy and migraine drug developed by Ortho-McNeil Janssen Pharmaceuticals and marketed by Johnson & Johnson, and Topiramate, the generic version sold by Teva Pharmaceuticals, Watson Pharmaceuticals and Mylan.
Topamax® and Topiramate lawsuit claims potentially being investigated include claims by women who were treated with Topamax® or Topiramate during pregnancy and gave birth to children born with oral cleft defects such as cleft lip or cleft palate.
On March 4, 2011, the U.S. Food and Drug Administration (FDA) issued a drug safety communication informing the public of new data that reportedly shows that there may be an increased risk for the development of cleft lip and/or cleft palate (oral clefts) in infants born to women treated with topiramate (Topamax® and generic products) during their first trimester of pregnancy.
Cleft lip or cleft palate may affect the formation and visual appearance of the upper lip or roof of the mouth of a child and can lead to issues with the child’s feeding or eating, talking and speech issues and ear infections. Children with cleft lip or cleft palate also may require revision surgery to correct and treat the birth defect.
If you or someone you love have taken Topamax® or Topiramate and gave birth to a child with cleft lip and/or cleft palate, you may be entitled to compensation. Contact a lawyer for a free review.*
*If you or a loved one have taken Topamax® or Topiramate and are experiencing health issues or side effects or have medical questions, we urge you to promptly consult with your doctor or physician.
*The listing of a company, product or activity is not meant to state or imply that the company acted illegally or improperly, that the activity is illegal or improper or that the product is unsafe or defective; rather only that an investigation may be, is or was being conducted to determine whether legal rights have been violated.
*Topamax® is trademark of Ortho-McNeil Janssen Pharmaceuticals, Inc. The use of this trademark is solely for product identification and informational purposes.
Fill out the form on the right for a free